InspireMD

About:

InspireMD is a medical device company focusing on the development and commercialization of its proprietary stent system technology, MGuard.

Website: http://www.inspiremd.com/en/

Twitter/X: InspireMD

Top Investors: Hercules Capital, OrbiMed, Marshall Wace, Soleus Capital, Nantahala Capital Management

Description:

InspireMD is an innovative medical device company focusing on the development and commercialization of its proprietary stent system technology, MGuard. The company intends to apply its technology to develop products used in interventional cardiology and other vascular procedures. InspireMD’s mission is to utilize its proprietary technology to make its products the industry standard for stents and to provide a superior solution to the key clinical issues of current stenting: embolic showers, restenosis, and late stent thrombosis. InspireMD intends to pursue applications of its innovative technology both for bare metal and drug eluting stents in coronary, carotid and peripheral artery procedures.

Total Funding Amount:

$224M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Tel Aviv, Tel Aviv, Israel

Founded Date:

2005-01-01

Founders:

Ofir Paz

Number of Employees:

51-100

Last Funding Date:

2024-07-01

IPO Status:

Public

Industries:

© 2025 bioDAO.ai